Cargando…

A Phase I Randomized Study of a Specifically Engineered, pH‐Sensitive PCSK9 Inhibitor RN317 (PF‐05335810) in Hypercholesterolemic Subjects on Statin Therapy

This phase I study assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of RN317 (PF‐05335810), a specifically engineered, pH‐sensitive, humanized proprotein convertase subtilisin kexin type 9 (PCSK9) monoclonal antibody, in hypercholesterolemic subjects (low‐density lipoprotein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levisetti, M, Joh, T, Wan, H, Liang, H, Forgues, P, Gumbiner, B, Garzone, PD
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351011/ https://www.ncbi.nlm.nih.gov/pubmed/27860267 http://dx.doi.org/10.1111/cts.12430

Ejemplares similares

Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-α, in Adults with Type 1 Diabetes
por: Williams, Jason H., et al.
Publicado: (2020)

Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects
por: Yokote, Koutaro, et al.
Publicado: (2019)

Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject
por: Larrea-Sebal, Asier, et al.
Publicado: (2023)

Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients
por: Fogacci, Federica, et al.
Publicado: (2022)

Independent association of PCSK9 with platelet reactivity in subjects without statin or antiplatelet agents
por: Wang, Shuai, et al.
Publicado: (2022)

Vascular and Metabolic Response to Statin in the Mildly Hypertensive Hypercholesterolemic Elderly
por: Crisostomo, Luciola M L, et al.
Publicado: (2008)

In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
por: Carreras, Alba, et al.
Publicado: (2019)

May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?
por: Scicali, Roberto, et al.
Publicado: (2020)

Neuroprotective Effects of Low-Dose Statins in the Retinal Ultrastructure of Hypercholesterolemic Rabbits
por: Fernández-Navarro, Judith, et al.
Publicado: (2016)

PCSK9 Levels and Metabolic Profiles in Elderly Subjects with Different Glucose Tolerance under Statin Therapy
por: Mäkelä, Kari A., et al.
Publicado: (2021)

Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
por: Schindler, Christoph, et al.
Publicado: (2014)

New isotope $^{227}$Rn and revised halflives for $^{223}$Rn and $^{226}$Rn
por: García-Borge, M J, et al.
Publicado: (1986)

Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center
por: Shah, Parth, et al.
Publicado: (2016)

Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
por: Choi, Jah Yeon, et al.
Publicado: (2019)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
por: LaFratte, Christopher, et al.
Publicado: (2023)

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2012)

Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice
por: Morgado, Manuel, et al.
Publicado: (2011)

Correction: Statin Treatment in Hypercholesterolemic Men Does Not Attenuate Angiotensin II-Induced Venoconstriction
Publicado: (2014)

Factors Affecting Adherence to Statins in Hypercholesterolemic Kuwaiti Patients: A Cross-Sectional Study
por: Al-Foraih, Meisa, et al.
Publicado: (2017)

Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method
por: Müller, Thomas, et al.
Publicado: (2023)

Interview With Andrea Mazzoccoli, RN, PhD, MSN, MBA, FAAN
por: Spitzer, Roxane
Publicado: (2020)

Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk
por: Silla, Alessia, et al.
Publicado: (2023)

Effects of Ezetimibe Added to Ongoing Statin Therapy on C-Reactive Protein Levels in Hypercholesterolemic Patients
por: Oh, Min Seok, et al.
Publicado: (2011)

Statins effect on insulin resistance after a meal and exercise in hypercholesterolemic pre‐diabetic individuals
por: Alvarez‐Jimenez, Laura, et al.
Publicado: (2022)

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans
por: Mayne, Janice, et al.
Publicado: (2008)

Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment
por: Sliz, Eeva, et al.
Publicado: (2018)

Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
por: Barkas, Fotios, et al.
Publicado: (2021)

Effect of Black Garlic Consumption on Endothelial Function and Lipid Profile: A Before-and-After Study in Hypercholesterolemic and Non-Hypercholesterolemic Subjects
por: Villaño, Débora, et al.
Publicado: (2023)

New isotope $^{227}$Rn and revised half lives for $^{223}$Rn and $^{226}$Rn
por: Nybø, K
Publicado: (1987)

CERN Proposal SPSC/P317; the CLOUD experiment
por: Kirkby, Jasper, et al.
Publicado: (2004)

Circulating Mature PCSK9 Level Predicts Diminished Response to Statin Therapy
por: Kuyama, Naoto, et al.
Publicado: (2021)

The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects
por: Acuff, Robert V, et al.
Publicado: (2007)

Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects
por: Morales, Cristian, et al.
Publicado: (2022)

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)
por: LIU, Yu-Qi, et al.
Publicado: (2021)

Missa KV 317 Krönungsmesse = Coronation mass = Messe du couronnement /
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1992)

Genomic characterization of five deletions in the LDL receptor gene in Danish Familial Hypercholesterolemic subjects
por: Nissen, Peter H, et al.
Publicado: (2006)

Redetermination of 5α-androstane-3,17-dione
por: Jasinski, Jerry P., et al.
Publicado: (2010)

ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis
por: Su, Jia, et al.
Publicado: (2015)

The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function
por: Di Costanzo, Assunta, et al.
Publicado: (2023)

Bacterial Community Profile of the Gut Microbiota Differs between Hypercholesterolemic Subjects and Controls
por: Rebolledo, Camilo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bdgkbgsrlkrjuatui54n693dac